AzTrials
AzTrials

Nasal SurgeryNCT07622745

Nasal Surgery in Snoring and Obstructive Sleep Apnea

A study testing Septoplasty with partial inferior turbinectomy, Nasal polypectomy and Partial inferior turbinectomy in people with Nasal Surgery and Snoring, run by Al-Azhar University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to evaluate the effect of isolated nasal surgery on sleep-disordered breathing, particularly apnea-hypopnea index (AHI) and snoring index (SI), Apnea index (AI) and minimal arterial oxygen saturation (MAO2) in adults with obstructive sleep apnea syndrome (OSAS) and nasal obstruction. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Nasal Surgery, Snoring, Obstructive Sleep Apnea
What is being tested?
Septoplasty with partial inferior turbinectomy, Nasal polypectomy and Partial inferior turbinectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteEgypt
Study dates
1 Mar 2022to 1 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age above 18 years.
  • Both sexes.
  • Patients with anatomical nasal obstruction due to septal deviation, hypertrophied inferior turbinate (HIT), or nasal polyps refractory to medical treatment.
  • Presence of snoring and obstructive sleep apnea (OSA).
  • Fitness for surgery.

Who cannot join

  • Central or mixed sleep apnea.
  • Previous nasal surgery.
  • Unfitness for surgery.
  • Pathological obesity.
  • History of cardiopulmonary disease or asthma.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Al-Azhar University

    Cairo, 11651

Other trials in Egypt

About this study

Official title: Role of Nasal Surgery in Snoring and Obstructive Sleep Apnea

This study aimed to evaluate the effect of isolated nasal surgery on sleep-disordered breathing, particularly apnea-hypopnea index (AHI) and snoring index (SI), Apnea index (AI) and minimal arterial oxygen saturation (MAO2) in adults with obstructive sleep apnea syndrome (OSAS) and nasal obstruction.

Read the detailed description

Snoring is the noisy breathing that occurs throughout sleep, resulting from the vibration of the structures in the oral cavity, including the soft palate, uvula, tonsils, base of the tongue, epiglottis, as well as pharyngeal walls.

Obstructive sleep apnea syndrome (OSAS) is a respiratory sleep disorder distinguished by repeated episodes of partial or total occlusion of the upper airways throughout sleep. This blockage is typically associated with a decrease (hypopnea) or total cessation (apnea) of airflow in the upper airways, and sustained thoracic-diaphragmatic respiratory movements.

Being tested
Septoplasty with partial inferior turbinectomy, Nasal polypectomy, Partial inferior turbinectomy
Medical subject headings
Snoring, Sleep Apnea, Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Septoplasty with partial inferior turbinectomyProcedure or surgery

    Patients with nasal septal deviation and hypertrophied inferior turbinate (HIT) who underwent septoplasty with partial inferior turbinectomy.

  • Nasal polypectomyProcedure or surgery

    Patients with chronic rhinosinusitis with nasal polyps who underwent functional endoscopic sinus surgery (FESS) with nasal polypectomy.

  • Partial inferior turbinectomyProcedure or surgery

    Patients with isolated hypertrophied inferior turbinate (HIT) who underwent partial inferior turbinectomy alone.

Study groups in NCT07622745
Study groupRoleWhat they receive
Group IExperimentalPatients with nasal septal deviation and hypertrophied inferior turbinate (HIT) who underwent septoplasty with partial inferior turbinectomy.
Receives: Procedure: Septoplasty with partial inferior turbinectomy
Group IIExperimentalPatients with chronic rhinosinusitis with nasal polyps who underwent functional endoscopic sinus surgery (FESS) with nasal polypectomy.
Receives: Procedure: Nasal polypectomy
Group IIIExperimentalPatients with isolated hypertrophied inferior turbinate (HIT) who underwent partial inferior turbinectomy alone.
Receives: Procedure: Partial inferior turbinectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Apnea-Hypopnea Index

    The Apnea-Hypopnea Index (AHI) is a critical metric used to diagnose and rank the severity of sleep apnea. It measures the average number of times your breathing completely stops (apneas) or becomes severely shallow (hypopneas) per hour of sleep.

    Measured: 3 months postoperatively

Secondary outcomes (1)
  1. Snoring index

    The snoring index was defined as the number of snoring episodes divided by the hours of total sleep time

    Measured: 3 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2026
  2. Study start1 Mar 2022
  3. Primary completion1 Jul 2024
  4. Study completion1 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07622745
Sponsor's protocol ID
1225
Status last verified
Jun 2026
First submitted
23 May 2026
Last updated
3 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

A study testing Septoplasty with partial inferior turbinectomy, Nasal polypectomy and Partial inferior turbinectomy in people with Nasal Surgery and Snoring, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Apnea-Hypopnea Index (time frame: 3 months postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in